Humana (HUM) Stock Price, News & Analysis

Company Overview

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Key Stats

• Today's Range: $242.22 to $256.39
• 50-Day Range: $249.32 to $303.57
• 52-Week Range: $213.31 to $406.46
• Volume: 1.81 million shs
• Average Volume: 1.72 million shs
• Market Capitalization: $30.83 billion
• P/E Ratio: 25.67
• Dividend Yield: 1.39%
• Price Target: $280.17
• Consensus Rating: Hold

Humana Stock Analysis - MarketRank™

Humana scored higher than 78% of companies evaluated by MarketBeat, and ranked 105th out of 901 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.1 / 5
• Analyst Rating: Hold

Consensus Rating

Humana has received a consensus rating of Hold. The company's average rating score is 2.19, and is based on 4 buy ratings, 17 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Humana has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: -20.28%

Earnings Growth

Earnings for Humana are expected to decrease by -20.28% in the coming year, from $16.47 to $13.13 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Humana is 25.67, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 20.62.

Price to Earnings Ratio vs. Sector

The P/E ratio of Humana is 25.67, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.79.

Price to Earnings Growth Ratio

Humana has a PEG Ratio of 2.05. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Humana has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.77% of the float of Humana has been sold short.

Short Interest Ratio / Days to Cover

Humana has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Humana has recently decreased by 9.02%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Humana pays a meaningful dividend of 1.33%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Humana does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Humana is 35.58%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Humana will have a dividend payout ratio of 26.96% next year. This indicates that Humana will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.9 / 5
• Environmental Score: -0.75

Percentage of Shares Shorted

2.77% of the float of Humana has been sold short.

Short Interest Ratio / Days to Cover

Humana has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Humana has recently decreased by 9.02%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 1.12

News Sentiment

Humana has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 27 news articles for Humana this week, compared to 22 articles on an average week.

Search Interest

Only 7 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -61% compared to the previous 30 days.

MarketBeat Follows

13 people have added Humana to their MarketBeat watchlist in the last 30 days. This is an increase of 18% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Humana insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.37% of the stock of Humana is held by insiders.

Percentage Held by Institutions

92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

HUM Stock Analysis - Frequently Asked Questions

How have HUM shares performed this year?

Humana's stock was trading at $253.71 at the beginning of the year. Since then, HUM shares have increased by 0.7% and is now trading at $255.4150.
View the best growth stocks for 2025 here.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) announced its quarterly earnings results on Tuesday, February, 11th. The insurance provider reported ($2.16) EPS for the quarter, beating the consensus estimate of ($2.26) by $0.10. Humana had a trailing twelve-month return on equity of 11.70% and a net margin of 1.02%.
Read the conference call transcript.

Does Humana have any subsidiaries?

Humana subsidiaries include these companies: Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and more.

Who are Humana's major shareholders?

Humana's top institutional investors include GAMMA Investing LLC (0.65%), First Hawaiian Bank (0.01%), Central Pacific Bank Trust Division and Versant Capital Management Inc. Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Timothy S Huval, Samir Deshpande, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming.
View institutional ownership trends.

How do I buy shares of Humana?

Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), DiamondRock Hospitality (DRH), American Water Works (AWK), AUO (AUOTY) and Triple Flag Precious Metals (TFPM).

Company Calendar

• Record date for 1/31 Dividend: 12/31/2024
• Ex-Dividend for 1/31 Dividend: 12/31/2024
• Dividend Payable: 1/31/2025
• Last Earnings: 2/11/2025
• Record date for 4/25 Dividend: 3/28/2025
• Ex-Dividend for 4/25 Dividend: 3/28/2025
• Today: 4/07/2025
• Dividend Payable: 4/25/2025
• Next Earnings (Estimated): 4/30/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Hospital & medical service plans
• Sub-Industry: Managed Health Care
• Current Symbol: NYSE:HUM
• CIK: 49071
• Web: www.humana.com
• Phone: (502) 580-1000
• Fax: 502-580-3639
• Employees: 67,100
• Year Founded: 1961

Price Target and Rating

• Average Stock Price Target: $280.17
• High Stock Price Target: $374.00
• Low Stock Price Target: $250.00
• Potential Upside/Downside: +10.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.19
• Research Coverage: 21 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $9.95
• Trailing P/E Ratio: 25.42
• Forward P/E Ratio: 15.34
• P/E Growth: 2.05
• Net Income: $1.21 billion
• Net Margins: 1.02%
• Pretax Margin: 1.46%
• Return on Equity: 11.70%
• Return on Assets: 3.99%

Debt

• Debt-to-Equity Ratio: 0.68
• Current Ratio: 1.76
• Quick Ratio: 1.76

Sales & Book Value

• Annual Sales: $117.76 billion
• Price / Sales: 0.26
• Cash Flow: $22.22 per share
• Price / Cash Flow: 11.37
• Book Value: $136.57 per share
• Price / Book: 1.85

Miscellaneous

• Outstanding Shares: 120,693,000
• Free Float: 120,026,000
• Market Cap: $30.49 billion
• Optionable: Optionable
• Beta: 0.62